{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:19:35Z","timestamp":1782472775884,"version":"3.54.5"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Transmission of drug-resistant HIV strains to treatment-na\u00efve patients can compromise antiretroviral therapy (ART) effectiveness and lead to treatment failure. In Pakistan, transmitted HIV drug resistance among people who inject drugs (PWID) is fuelled by a lack of harm reduction, ART, poor drug adherence, and unsafe injection practices, resulting in efficient transmission in large injecting networks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted among PWID recruited in Karachi, Larkana, Peshawar, Quetta and Hyderabad (August to December 2014). A portion of the HIV pol gene was amplified from HIV-reactive dried blood spot specimens (n\u200a=\u200a282\/367) and sequenced using an in-house Sanger sequencing assay for HIV drug resistance mutation (DRM) genotyping. DRMs were identified using the Stanford University HIV Drug Resistance Database (https:\/\/hivdb.stanford.edu\/hivdb).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, HIV subtype A1 was dominant (78.0%; n\u200a=\u200a220), followed by CRF02_AG (15.6%; n\u200a=\u200a44), CRF35_AD (2.5% n\u200a=\u200a7), recombinants (3.5%; n\u200a=\u200a10), and subtype C (0.4% n\u200a=\u200a1). DRM analysis identified that over half (63.8%) of participants harboured at least one DRM, of which 28.9% reported using help from a professional injector. Nearly all (99.4%) participants were not actively receiving ART because most (88.7%) had never undergone HIV testing and were unaware of their status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Findings suggest significant transmitted HIV drug resistance present among PWID, exacerbated by unsafe injection practices, particularly professional injection. Low testing rates signal a need for more comprehensive testing programs to improve HIV status awareness and ART coverage in Pakistan. These gaps remain especially urgent given persistent challenges in the national response, including low ART coverage, poor adherence, and limited access to genotypic resistance testing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkaf425","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:26:15Z","timestamp":1762881975000},"source":"Crossref","is-referenced-by-count":2,"title":["Notable transmitted HIV drug resistance among people who inject drugs in Pakistan"],"prefix":"10.1093","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8509-6310","authenticated-orcid":false,"given":"Stephanie","family":"Melnychuk","sequence":"first","affiliation":[{"name":"Institute for Global Public Health, College of Community and Global Health, University of Manitoba , Winnipeg ,","place":["Canada"]},{"name":"National Sexually Transmitted and Blood Borne Infections Laboratory, National Microbiology Laboratory at the J.C. Wilt Infectious Diseases Research Centre, Public Health Agency of Canada , Winnipeg ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura H","family":"Thompson","sequence":"additional","affiliation":[{"name":"Sexually Transmitted and Bloodborne Infections Surveillance Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada , Ottawa, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Archibald","sequence":"additional","affiliation":[{"name":"Sexually Transmitted and Bloodborne Infections Surveillance Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada , Ottawa, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F","family":"Blanchard","sequence":"additional","affiliation":[{"name":"Institute for Global Public Health, College of Community and Global Health, University of Manitoba , Winnipeg ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faran","family":"Emmanuel","sequence":"additional","affiliation":[{"name":"Institute for Global Public Health, College of Community and Global Health, University of Manitoba , Winnipeg ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahira","family":"Reza","sequence":"additional","affiliation":[{"name":"Centre for Global Public Health, Pakistan , Chak Shahzad, Islamabad ,","place":["Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosheen","family":"Dar","sequence":"additional","affiliation":[{"name":"Canada-Pakistan HIV\/AIDS Surveillance Project , Islamabad ,","place":["Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sandstrom","sequence":"additional","affiliation":[{"name":"National Sexually Transmitted and Blood Borne Infections Laboratory, National Microbiology Laboratory at the J.C. Wilt Infectious Diseases Research Centre, Public Health Agency of Canada , Winnipeg ,","place":["Canada"]},{"name":"Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba , Winnipeg ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souradet Y","family":"Shaw","sequence":"additional","affiliation":[{"name":"Institute for Global Public Health, College of Community and Global Health, University of Manitoba , Winnipeg ,","place":["Canada"]},{"name":"Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba , Winnipeg ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa L","family":"Becker","sequence":"additional","affiliation":[{"name":"Institute for Global Public Health, College of Community and Global Health, University of Manitoba , Winnipeg ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Cholette","sequence":"additional","affiliation":[{"name":"National Sexually Transmitted and Blood Borne Infections Laboratory, National Microbiology Laboratory at the J.C. Wilt Infectious Diseases Research Centre, Public Health Agency of Canada , Winnipeg ,","place":["Canada"]},{"name":"Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba , Winnipeg ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"2026011413271933300_dkaf425-B1","author":"UNAIDs"},{"key":"2026011413271933300_dkaf425-B2","author":"UNAIDs"},{"key":"2026011413271933300_dkaf425-B3","doi-asserted-by":"publisher","first-page":"ofab457","DOI":"10.1093\/ofid\/ofab457","article-title":"Elucidating drivers for variations in the explosive human immunodeficiency virus epidemic among people who inject drugs in Pakistan","volume":"8","author":"Lim","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2026011413271933300_dkaf425-B4","doi-asserted-by":"publisher","first-page":"104797","DOI":"10.1016\/j.amsu.2022.104797","article-title":"HIV in Pakistan: challenges, efforts and recommendations","volume":"84","author":"Salman","year":"2022","journal-title":"Ann Med Surg"},{"key":"2026011413271933300_dkaf425-B5","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1089\/aid.2010.0324","article-title":"Antiretroviral drug resistance mutations among treated and treatment-naive patients in Pakistan: diversity of the HIV type 1 pol gene in Pakistan","volume":"27","author":"Shah","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2026011413271933300_dkaf425-B6","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/20477724.2023.2191234","article-title":"Risk factors of HIV and variation in access to clean needles among people who inject drugs in Pakistan","volume":"117","author":"Capelastegui","year":"2023","journal-title":"Pathog Glob Health"},{"key":"2026011413271933300_dkaf425-B7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12954-015-0079-5","article-title":"Drug-related HIV epidemic in Pakistan: a review of current situation and response and the way forward beyond 2015","volume":"12","author":"Bergenstrom","year":"2015","journal-title":"Harm Reduct J"},{"key":"2026011413271933300_dkaf425-B8","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s10461-008-9489-7","article-title":"Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis","volume":"14","author":"Malta","year":"2010","journal-title":"AIDS Behav"},{"key":"2026011413271933300_dkaf425-B9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/QAD.0000000000000642","article-title":"The causal effect of opioid substitution treatment on HAART medication refill adherence","volume":"29","author":"Nosyk","year":"2015","journal-title":"AIDS"},{"key":"2026011413271933300_dkaf425-B10","author":"Nai Zindagi Trust"},{"key":"2026011413271933300_dkaf425-B11","doi-asserted-by":"publisher","first-page":"103281","DOI":"10.1016\/j.drugpo.2021.103281","article-title":"Adherence to antiretroviral therapy among HIV positive men who inject drugs in Pakistan","volume":"96","author":"Iversen","year":"2021","journal-title":"Int J Drug Policy"},{"key":"2026011413271933300_dkaf425-B12","first-page":"437","article-title":"Anti-retroviral drugs compliance in intravenous and non intravenous drug abusers","volume":"26","author":"Daud","year":"2014","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"2026011413271933300_dkaf425-B13","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1086\/378301","article-title":"Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance","volume":"37","author":"Sethi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2026011413271933300_dkaf425-B14","author":"WHO"},{"key":"2026011413271933300_dkaf425-B15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.idc.2019.05.004","article-title":"Management of virologic failure and HIV drug resistance","volume":"33","author":"McCluskey","year":"2019","journal-title":"Infect Dis Clin North Am"},{"key":"2026011413271933300_dkaf425-B16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12977-018-0395-4","article-title":"HIV evolution and diversity in ART-treated patients","volume":"15","author":"van Zyl","year":"2018","journal-title":"Retrovirology"},{"key":"2026011413271933300_dkaf425-B17","doi-asserted-by":"publisher","first-page":"e579","DOI":"10.1016\/S2352-3018(16)30119-9","article-title":"Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey","volume":"3","author":"\u00c1vila-R\u00edos","year":"2016","journal-title":"Lancet HIV"},{"key":"2026011413271933300_dkaf425-B18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S1473-3099(17)30702-8","article-title":"HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis","volume":"18","author":"Gupta","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2026011413271933300_dkaf425-B19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S1473-3099(11)70255-9","article-title":"Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study","volume":"12","author":"Hamers","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"2026011413271933300_dkaf425-B20","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/QAD.0000000000001039","article-title":"HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks","volume":"30","author":"Des Jarlais","year":"2016","journal-title":"AIDS"},{"key":"2026011413271933300_dkaf425-B21","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1097\/QAD.0000000000000494","article-title":"Global burden of transmitted HIV drug resistance and HIV-exposure categories: a systematic review and meta-analysis","volume":"28","author":"Pham","year":"2014","journal-title":"AIDS"},{"key":"2026011413271933300_dkaf425-B22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/QAI.0b013e31819906f3","article-title":"Factors associated with an explosive HIV epidemic among injecting drug users in Sargodha, Pakistan","volume":"51","author":"Emmanuel","year":"2009","journal-title":"JAIDS"},{"key":"2026011413271933300_dkaf425-B23","doi-asserted-by":"publisher","first-page":"e81715","DOI":"10.1371\/journal.pone.0081715","article-title":"High HIV incidence among persons who inject drugs in Pakistan: greater risk with needle sharing and injecting frequently among the homeless","volume":"8","author":"Samo","year":"2013","journal-title":"PLoS One"},{"key":"2026011413271933300_dkaf425-B24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0140-6736(10)60743-X","article-title":"HIV and risk environment for injecting drug users: the past, present, and future","volume":"376","author":"Strathdee","year":"2010","journal-title":"Lancet"},{"key":"2026011413271933300_dkaf425-B25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00705-017-3564-1","article-title":"HIV-1 genetic diversity, geographical linkages and antiretroviral drug resistance among individuals from Pakistan","volume":"163","author":"Khan","year":"2018","journal-title":"Arch Virol"},{"key":"2026011413271933300_dkaf425-B26","doi-asserted-by":"publisher","first-page":"e0290425","DOI":"10.1371\/journal.pone.0290425","article-title":"Genetic and antiretroviral drug resistance mutations analysis of reverse transcriptase and protease gene from Pakistani people living with HIV-1","volume":"18","author":"Siddiqui","year":"2023","journal-title":"PLoS One"},{"key":"2026011413271933300_dkaf425-B27","doi-asserted-by":"publisher","first-page":"658186","DOI":"10.3389\/fmicb.2021.658186","article-title":"Phylogenetic and drug-resistance analysis of HIV-1 sequences from an extensive paediatric HIV-1 outbreak in Larkana, Pakistan","volume":"12","author":"Abidi","year":"2021","journal-title":"Front Microbiol"},{"key":"2026011413271933300_dkaf425-B28","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1097\/01.aids.0000386737.25296.c4","article-title":"The HIV\/AIDS surveillance project mapping approach: an innovative approach for mapping and size estimation for groups at a higher risk of HIV in Pakistan","volume":"24","author":"Emmanuel","year":"2010","journal-title":"AIDS"},{"key":"2026011413271933300_dkaf425-B29","doi-asserted-by":"publisher","first-page":"e0237560","DOI":"10.1371\/journal.pone.0237560","article-title":"HIV-1 phylodynamic analysis among people who inject drugs in Pakistan correlates with trends in illicit opioid trade","volume":"15","author":"Cholette","year":"2020","journal-title":"PLoS One"},{"key":"2026011413271933300_dkaf425-B30","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1128\/JCM.06689-11","article-title":"Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool","volume":"50","author":"Woods","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2026011413271933300_dkaf425-B31","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/molbev\/msy096","article-title":"MEGA X: molecular evolutionary genetics analysis across computing platforms","volume":"35","author":"Kumar","year":"2018","journal-title":"Mol Biol Evol"},{"key":"2026011413271933300_dkaf425-B32","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1093\/nar\/gku739","article-title":"COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification","volume":"42","author":"Struck","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2026011413271933300_dkaf425-B33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.meegid.2013.04.032","article-title":"Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools","volume":"19","author":"Pineda-Pe\u00f1a","year":"2013","journal-title":"Infect Genet Evol"},{"key":"2026011413271933300_dkaf425-B34","doi-asserted-by":"publisher","first-page":"e1000581","DOI":"10.1371\/journal.pcbi.1000581","article-title":"An evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1","volume":"5","author":"Pond","year":"2009","journal-title":"PLoS Comput Biol"},{"key":"2026011413271933300_dkaf425-B35","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/nar\/gkg100","article-title":"Human immunodeficiency virus reverse transcriptase and protease sequence database","volume":"31","author":"Rhee","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"2026011413271933300_dkaf425-B36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"Scipy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat Methods"},{"key":"2026011413271933300_dkaf425-B37","author":"WHO"},{"key":"2026011413271933300_dkaf425-B38","doi-asserted-by":"publisher","first-page":"e05373","DOI":"10.1002\/ccr3.5373","article-title":"Pre-existing singleton E138A mutations in the reverse transcriptase gene do not affect the efficacy of first-line antiretroviral therapy regimens using rilpivirine in human immunodeficiency virus-infected patients","volume":"10","author":"Kuznetsova","year":"2022","journal-title":"Clin Case Rep"},{"key":"2026011413271933300_dkaf425-B39","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1128\/AAC.00348-13","article-title":"Effect of mutations at position E138 in HIV-1 reverse transcriptase and their interactions with the M184I mutation on defining patterns of resistance to nonnucleoside reverse transcriptase inhibitors rilpivirine and etravirine","volume":"57","author":"Xu","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413271933300_dkaf425-B40","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3390\/v16060962","article-title":"Human immunodeficiency virus type-1 genetic diversity and drugs resistance mutations among people living with HIV in Karachi, Pakistan","volume":"16","author":"Rashid","year":"2024","journal-title":"Viruses"},{"key":"2026011413271933300_dkaf425-B41","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1128\/AAC.01536-13","article-title":"Role of the K101E substitution in HIV-1 reverse transcriptase in resistance to rilpivirine and other nonnucleoside reverse transcriptase inhibitors","volume":"57","author":"Xu","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413271933300_dkaf425-B42","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1089\/aid.2014.0368","article-title":"Short communication: increase of HIV-1 K103N transmitted drug resistance and its association with Efavirenz use in South Korea","volume":"31","author":"Chin","year":"2015","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2026011413271933300_dkaf425-B43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1742-6405-11-36","article-title":"The development of drug resistance mutations K103N Y181C and G190A in long term Nevirapine-containing antiviral therapy","volume":"11","author":"Wang","year":"2014","journal-title":"AIDS Res Ther"},{"key":"2026011413271933300_dkaf425-B44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12879-020-05007-5","article-title":"Natural presence of the V179D and K103R\/V179D mutations associated with resistance to nonnucleoside reverse transcriptase inhibitors in HIV-1 CRF65_cpx strains","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Infect Dis"},{"key":"2026011413271933300_dkaf425-B45","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1128\/AAC.04215-14","article-title":"Impact of drug resistance-associated amino acid changes in HIV-1 subtype C on susceptibility to newer nonnucleoside reverse transcriptase inhibitors","volume":"59","author":"Basson","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413271933300_dkaf425-B46","author":"NACP"},{"key":"2026011413271933300_dkaf425-B47","doi-asserted-by":"publisher","first-page":"100878","DOI":"10.1016\/j.cegh.2021.100878","article-title":"HIV\/AIDS among children in Ratodero, Pakistan amidst the COVID-19 pandemic: challenges, efforts, and recommendations","volume":"12","author":"Mohan","year":"2021","journal-title":"Clin Epidemiol Glob Health"},{"key":"2026011413271933300_dkaf425-B48","author":"WHO"},{"key":"2026011413271933300_dkaf425-B49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.drugpo.2007.12.012","article-title":"Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed","volume":"19","author":"Emmanuel","year":"2008","journal-title":"Int J Drug Policy"},{"key":"2026011413271933300_dkaf425-B50","doi-asserted-by":"publisher","first-page":"ii18","DOI":"10.1136\/sextrans-2012-050775","article-title":"Geographical and temporal variation of injection drug users in Pakistan","volume":"89","author":"Archibald","year":"2013","journal-title":"Sex Transm Infect"},{"key":"2026011413271933300_dkaf425-B51","doi-asserted-by":"publisher","first-page":"iii23","DOI":"10.1136\/sextrans-2013-051161","article-title":"Second-generation surveillance for HIV\/AIDS in Pakistan: results from the 4th round of Integrated Behavior and Biological Survey 2011\u20132012","volume":"89","author":"Emmanuel","year":"2013","journal-title":"Sex Transm Infect"},{"key":"2026011413271933300_dkaf425-B52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1477-7517-6-13","article-title":"Large sharing networks and unusual injection practices explain the rapid rise in HIV among IDUs in Sargodha, Pakistan","volume":"6","author":"Khan","year":"2009","journal-title":"Harm Reduct J"},{"key":"2026011413271933300_dkaf425-B53","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.5455\/JPMA.30590","article-title":"Is Pakistan at the cusp of an ART resistance?","volume":"70","author":"Altaf","year":"2020","journal-title":"J Pak Med Assoc"},{"key":"2026011413271933300_dkaf425-B54","doi-asserted-by":"publisher","first-page":"e0003882","DOI":"10.1371\/journal.pgph.0003882","article-title":"Prevalence and predictors of depressive symptoms among people living with HIV in Pakistan; country-wide secondary data analysis from National Stigma Index Study","volume":"4","author":"Ali","year":"2024","journal-title":"PLOS Glob Public Health"},{"key":"2026011413271933300_dkaf425-B55","author":"The Association of People Living with HIV & AIDS\u2014Pakistan"},{"key":"2026011413271933300_dkaf425-B56","doi-asserted-by":"publisher","first-page":"e357","DOI":"10.1016\/S2352-3018(17)30073-5","article-title":"HIV and the criminalisation of drug use among people who inject drugs: a systematic review","volume":"4","author":"DeBeck","year":"2017","journal-title":"Lancet HIV"},{"key":"2026011413271933300_dkaf425-B57","doi-asserted-by":"publisher","first-page":"104492","DOI":"10.1016\/j.amsu.2022.104492","article-title":"The rise in HIV cases in Pakistan: prospective implications and approaches","volume":"81","author":"Marfani","year":"2022","journal-title":"Ann Med Surg"},{"key":"2026011413271933300_dkaf425-B58","author":"NACP"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/1\/dkaf425\/65272199\/dkaf425.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/1\/dkaf425\/65272199\/dkaf425.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:27:21Z","timestamp":1768415241000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkaf425\/8321197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaf425","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,11,11]]},"article-number":"dkaf425"}}